CD274 and breast carcinoma: In addition, by inhibiting the Akt/mTOR/p70S6K pathway in tumor-bearing mice, APS downregulated the expression of PD-L1 on the surface of breast cancer 4T1 cells and colorectal cancer CT26 cells, and blocked PD-L1-induced T-cell exhaustion [137].